RovelizumabAgricultural BiotechnologyUpdated on Jun 4, 2020 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

Recombinant monoclonal antibody to CD18. Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.